Late-Breaking Data Demonstrate Significant Clinical Advantage of Elixir Medical s DynamX Bioadaptor Over Standard of Care Drug-Eluting Stent at Two Ye menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.
Global Drug Eluting Stent Research Report 2023: A $13 65 globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.
The Global Coronary Stents Industry is on a trajectory to attain a significant valuation of US$ 51.2 million by the year 2032, exhibiting a steady compound annual growth rate (CAGR) of 5.1% from 2022 to 2032. In 2022, the market is expected to hit an estimated value of US$ 33.36 million.The market’s growth is primar.